CHAMPIONS ONCOLOGY, INC.
CSBRChampions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 22, 2026
18dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How CSBR's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is CHAMPIONS ONCOLOGY, INC.'s next FDA catalyst?→
CHAMPIONS ONCOLOGY, INC.'s (CSBR) next tracked catalyst is a Earnings expected July 22, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CSBR biotech catalysts?→
Add CSBR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CHAMPIONS ONCOLOGY, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.